Dosage, Immunization and Pharmacy Management - Pharmacist Digest

Search:

DAY

WEEK

MONTH

YEAR

Jul 05 - Jul 11

Jun 28 - Jul 04

Jun 21 - Jun 27

Jun 14 - Jun 20

Jun 07 - Jun 13

MORE

MORE

MORE

MORE

Select your country:
Sign up | Log in

Dosage

Immunization

Pharmacy Management

article thumbnail

New Frontline BTK Inhibitor Strategy Gains FDA Approval in Untreated Mantle Cell Lymphoma

Pharmacy Times

JUNE 27, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Pharmacy Technician

Pharmacy Technician Diabetes Compounding Pharmacies Pharmacy Management

article thumbnail

Continuous Subcutaneous Lenalidomide Shows Promise in Reducing Toxicity in R/R Multiple Myeloma

Pharmacy Times

JUNE 25, 2025

The study aimed to evaluate both safety and preliminary efficacy outcomes, with a specific focus on hematologic toxicity, pharmacokinetics, and immune system effects. Flow cytometry data indicated no significant increases in immune checkpoint markers typically associated with T-cell exhaustion.

Pharmacy Technician

Pharmacy Technician Immunization Immunity Diabetes

Join 11,000+

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Daily CBD Use at Consumer-Level Doses May Elevate Liver Enzymes, FDA-Led Trial Shows

Pharmacy Times

JULY 12, 2025

Animal studies reveal dose-dependent hepatic responses to CBD, supporting the need for cautious monitoring even at consumer-relevant dosages. Pharmacists should review patient medication profiles, advise on appropriate dosage adjustments, and monitor for cumulative toxicity. of healthy adults, necessitating liver function monitoring.

Pharmacy Technician

Pharmacy Technician Dosage Compounding Pharmacies Pharmacy Management

article thumbnail

The Value of a Medically Integrated Pharmacy to Maximize Cost Avoidance and Reduce Waste of Oral Oncolytic Medications

Pharmacy Times

JUNE 17, 2025

Subscribe Now!

Mail-Order Pharmacies

Mail-Order Pharmacies Pharmacy Technician Compounding Pharmacies Inpatient

article thumbnail

Understanding Recent Changes to 505(b)(2) Drugs and Reimbursement

Pharmacy Times

JUNE 23, 2025

Additionally, ANDA submissions should extrapolate the RLD safety and effectiveness data for drugs with the same active ingredients, dosage forms, strengths, routes, and labeling. In the 505(j) ANDA approval pathway, on the other hand, submissions can be multisource generic drugs; however, this pathway requires bioequivalence to the RLD.

Pharmacy Technician

Pharmacy Technician Compounding Pharmacies Dosage Hospitals

article thumbnail

Lumateperone Submits Application for Schizophrenia Indication to FDA for Supplemental New Drug

Pharmacy Times

JULY 10, 2025

2 Guiding prescribers and patients through initiation of lumatperone, adjusting dosage amounts, and switching from other antipsychotics, emphasizing its favorable relapse reduction profile is key in preventing relapse.

Pharmacy Technician

Pharmacy Technician Hospitals Compounding Pharmacies Pharmacy Management

article thumbnail

Real-World Data Shows Similar Clinical Outcomes in Patients Receiving Biosimilars Following Switch From Reference Product

Pharmacy Times

JULY 4, 2025

The most common reason for exclusion was the patient opting out of clinical follow-up with the specialty pharmacy team. Both Hadlima and Hyrimoz share the same strengths and dosages and have no clinically meaningful differences from Humira when relieving patient symptoms.

Biosimilars Specialty Pharmacies Pharmacy Technician Hospitals

article thumbnail

Correct Patient Misconceptions Around Biosimilars

Pharmacy Times

JUNE 27, 2025

Generics are exact chemical copies of small-molecule drugs, with identical active ingredients, strengths, dosage forms, and routes of administration. Although generics and biosimilars offer lower-cost alternatives to brand-name drugs, they are not the same.

Biosimilars Pharmacy Technician Diabetes Compounding Pharmacies

article thumbnail

Because Ned Said: New Technology Helps Prevent Opioid Overdose

Pharmacy Times

JUNE 9, 2025

HME in drug manufacturing typically employs corotated twin extruders and uses heat and pressure to create solid dosage forms, dispersing the active pharmaceutical ingredient within a molten polymer matrix, and forming a solid solution or amorphous solid dispersion. trillion economic impact in 2020.

Pharmacy Technician

Pharmacy Technician Compounding Pharmacies Compounding Pharmacy Management

article thumbnail

Prevalence of Dosage Modifications and Impact on Response Milestone Among Patients With CML Treated With Imatinib Using RWD

Pharmacy Times

JUNE 17, 2025

A group of experts will present an encore abstract titled " Prevalence of Dosage Modifications and Impact on Response Milestone Among Patients With CML Treated With Imatinib Using Real-World Data " at the 2025 Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20.

Dosage

Dosage Pharmacy Technician Compounding Pharmacies Inpatient

article thumbnail

Unicorns Don’t Exist: Rethinking the Generalist Model in Oncology Pharmacy

Pharmacy Times

JUNE 20, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Pharmacy Technician

Pharmacy Technician Compounding Compounding Pharmacies Biosimilars

article thumbnail

Gabapentin Use Linked to Increased Dementia Risk in Chronic Back Pain Patients

Pharmacy Times

JULY 17, 2025

The study emphasizes the importance of pharmacist involvement in monitoring cognitive risks and managing long-term gabapentin therapy. Despite observational evidence, causation is not established, necessitating further research on dosage effects and neurocognitive outcomes.

Pharmacy Technician

Pharmacy Technician Compounding Pharmacies Pharmacy Management Immunization

article thumbnail

FDA Approves Meloxicam Injection For Moderate-to-Severe Pain in Adults

Pharmacy Times

JUNE 10, 2025

1 "[Meloxicam injection] demonstrates our commitment to improving patient care by providing an alternate dosage form for pain management," Ron Scarboro, chief executive officer at Azurity Pharmaceuticals, said in a press release.

Pharmacy Technician

Pharmacy Technician HIV Treatment and Prevention Agents Compounding Pharmacies Biosimilars

article thumbnail

CAR T and Beyond: The Expanding Pipeline and Promise of Cell Therapies

Pharmacy Times

JUNE 19, 2025

Trends Pharmacol Sci. 2024;45(5):406-418. doi:10.1016/j.tips.2024.03.004

Pharmacy Technician

Pharmacy Technician Diabetes Compounding Compounding Pharmacies

article thumbnail

Investigating the Pharmacist’s Role in Psychedelic-Assisted Psychotherapy for Patients With Cancer

Pharmacy Times

JUNE 27, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Pharmacy Technician

Pharmacy Technician Compounding Pharmacies Pharmacy Management Immunization

article thumbnail

Efepoetin Alfa Noninferior to Mircera When Correcting Anemia, Maintaining Hemoglobin in CKD

Pharmacy Times

JULY 7, 2025

Limitations included open-label design and dosage constraints, but the multicountry approach enhanced generalizability and external validity. All patients underwent a 20-week correction period for dosage titration and Hb correction, which was followed by an 8-week evaluation for efficacy assessments. 1 REFERENCES 1.

Pharmacy Technician

Pharmacy Technician Compounding Pharmacies Dosage Diabetes

article thumbnail

Study Shows High-Dose Vitamin D Boosts Treatment Response in Breast Cancer

Pharmacy Times

JUNE 13, 2025

2 Vitamin D Immunity Vitamin D is a crucial hormone that supports bone health by facilitating the absorption of calcium and phosphorus, which is obtained mainly from sunlight exposure and food. Vitamin D is an accessible and inexpensive option compared to other drugs used to improve the response to chemotherapy.” P = 0.04).

Chemotherapy Pharmacy Technician Immunization Immunity

article thumbnail

Self-Care Measures for Preventing and Managing Dysmenorrhea

Pharmacy Times

JUNE 20, 2025

Selection of an appropriate OTC analgesic should take into consideration various patient factors, including the patient’s overall health status, current medical conditions, and medication profile, as well as patient preferences, which are often influenced by dosage form, required dosing intervals, and cost of OTC medication.

Pharmacy Technician

Pharmacy Technician Compounding Pharmacies Hospitals Pharmacy Management

article thumbnail

FDA Approves Ustekinumab-Stba, Biosimilar to Stelara, for Pediatric Patients With PsO or PsA

Pharmacy Times

JUNE 16, 2025

Steqeyma provides a new dosage form and strength, enhancing treatment flexibility for young patients with chronic inflammatory conditions. 2,3 Steqeyma, which was formerly known as CT-P43, is a human IL-12 and IL-23 antagonist indicated for multiple immune-mediated diseases.

Biosimilars Pharmacy Technician Compounding Pharmacies Immunization

article thumbnail

INCB057643 in Combination with Ruxolitinib Improves Symptoms in Patients With Myelofibrosis

Pharmacy Times

JUNE 30, 2025

2,3 LIMBER is a phase 1, open-label, dose escalation study evaluating INCB057643 as a monotherapy at a dose escalation of 4 to 12 mg daily (part 1) or in combination with ruxolitinib at a dosage of 4 mg once daily and escalating to the maximum tolerated dose in part 1 (part 2).

Pharmacy Technician

Pharmacy Technician Compounding Pharmacies Compounding Pharmacy Management

article thumbnail

High Response Rates With Talquetamab Plus Teclistamab in Triple-Class Refractory Multiple Myeloma

Pharmacy Times

JUNE 16, 2025

The investigators assessed a total of 90 patients who received talquetamab at a dosage of 0.8 mg/kg once every 2 weeks plus teclistamab at a dosage of 3.0 2 As a combination therapy, talquetamab and teclistamab show significant promise in the phase 1b/2 dose escalation and expansion in the RedirecTT-1 trial (NCT04586426).

Pharmacy Technician

Pharmacy Technician Compounding Pharmacies Immunization Immunity

article thumbnail

Sequencing of Liposomal Daunorubicin/Cytarabine Versus Hypomethylating Agents Plus Venetoclax for Secondary Acute Myeloid Leukemia

Pharmacy Times

JUNE 18, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Pharmacy Technician

Pharmacy Technician Compounding Pharmacies Dosage Pharmacy Management

article thumbnail

Out of Shortage, Into Controversy: The Fight Over GLP-1 Compounding

Pharmacy Times

JULY 18, 2025

As depicted in Table 2 , if all of the following are true, then it is essentially a copy : same active pharmaceutical ingredient (API), same or easily substitutable dosage strength (this is set at greater than ±10%), and can be used by the same route of administration as prescribed for the compounded drug.

Compounding Pharmacy Technician Compounding Pharmacies Documentation

article thumbnail

Clinical Manifestations of Acute, Chronic Graft-vs-Host Disease With PTCy in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation

Pharmacy Times

JUNE 18, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Pharmacy Technician

Pharmacy Technician Compounding Pharmacies Dosage Pharmacy Management

article thumbnail

Blujepa From GSK

Pharmacy Times

JULY 18, 2025

1 About the Author Monica Holmberg, PharmD, BCPS, is a pharmacist in Phoenix, Arizona, and a Pharmacy Times contributor. DOSAGE AND ADMINISTRATION The recommended dose of gepotidacin is 1500 mg orally twice daily for 5 days. The medication should be taken after a meal to reduce gastrointestinal intolerance.

Pharmacy Technician

Pharmacy Technician Compounding Pharmacies Pharmacy Management Adverse Reactions